Zdrowie i gospodarka · 13/04/2022
FDA Clears TOTECT (Dexrazoxane Hydrochloride) for Injection, 500mg, for Continued Sale
The US Food and Drug Administration (FDA) has ruled that TOTECT, a 500mg injection, was not withdrawn from the market due to safety or efficacy concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for the product.